ECMO System from Hengrui Medical Has Gained NMPA Approval
Recently, Suzhou-based Hengrui Medical has announced its self-developed ECMO (Extracorporeal Membrane Oxygenation) system has been granted approval by the National Medical Products Administration (NMPA) in China.
According to Hengrui Medical, this fully-integrated ECMO system represents the first completely domestically produced solution in the Chinese market, marking a significant milestone for China’s capabilities in high-tech medical equipment manufacturing. The system includes key components such as the pump unit, blood circulation module, venous access set, warming device, and needle set. It incorporates cutting-edge domestic technologies like magnetic suspension blood pump technology and multi-mode control systems, significantly enhancing its stability and safety.
Through rigorous design and clinical trials, this ECMO system not only achieves expected therapeutic outcomes but also demonstrates exceptional performance in various test scenarios, ensuring high reliability for patients undergoing intensive care.
Technical Innovations
The ECMO system developed by Shuzhou Medical integrates advanced domestic technologies to provide enhanced therapeutic benefits. Key innovations include:
- Magnetic Suspension Blood Pump Technology : This technology ensures stable and reliable blood circulation during therapy.
- Multi-Mode Control System : The system operates efficiently across different clinical scenarios, ensuring optimal patient outcomes.
Disclaimer: The information on this platform is for informational purposes only and is based on publicly available sources, such as official press releases and regulatory databases. While we strive for accuracy, details may vary from the manufacturer’s official statements, particularly if they have been translated. We encourage readers to consult the manufacturer’s official website and communications for the most current and accurate information. This report is not a substitute for professional medical advice, diagnosis, or treatment and does not constitute an endorsement of any product or company. We do not accept responsibility for any errors, omissions, or actions taken based on the information provided.